FDA approves MolecuLight’s handheld fluorescence imaging device

MolecuLight Inc. has achieved a major regulatory milestone permitting expansion into the United States market. FDA has granted De Novo clearance for the ground-breaking...

Follow us

NHSE figures show the busiest July for A&E on record

Recent performance figures from NHS England show that the NHS continues to struggle. Despite initiatives put in place this year the heatwave amongst other...

New standards launched to improve public involvement in research

New national standards to improve the quality of public involvement in research.

Is Brexit good news for pharma?

James Burt, Executive Vice President EMENA, Accord Healthcare, asks whether Brexit will in fact present an opportunity for positive change in pharma and healthcare.

What do NHS changes mean for tech innovation?

Could changes at the top mean fresh opportunities for tech innovation? Read this in the August issue of Pf Magazine.  For some time it has been...

At the heart of it: The vital role of pharmacies in community health

Read this in the August issue of Pf Magazine.  Community pharmacy has a clear role in promoting and supporting the public’s health. There’s an accessible...

Novartis appoint Dr. Klaus Moosmayer as Chief Ethics, Risk & Compliance...

Novartis has announced the appointment of Dr Klaus Moosmayer as Chief Ethics, Risk and Compliance Officer. He will report to Vas Narasimhan, M.D., CEO...

Jobs of the week

Surgeon takes prostate cancer screening to the community

Surgeon Jyoti Shah won’t let men die of embarrassment. Instead of waiting for patients to come to her, she goes out and gets them.

What’s driving a resurgence in primary care pharma representatives?

After flirting with remote detailing, pharma is returning to feet-on-the-ground sales to meet the complex challenges of transforming markets and changing decision makers. Read this...

Two way street: Industry/patient dialogue and its role in market access

How can we make the pharma world more patient centric?

Pf Magazine August 2018

What's next for field sales?